Indian Pharmacopoeia Commission hosts scientific conclave to brainstorm on strengthening pharmaceutical quality and compliance
The filing is backed by results from the pivotal SERENA-6 Phase III trial
Stroke is the second-leading cause of death and the third-leading cause of disability worldwide
The backing comes as influenza remains a persistent public health burden
Country’s deep scientific talent pool and its growing role as a clinical trial destination makes it central to how Parexel serves sponsors
The decision was driven by results from the Phase III CAPItello-281 trial,
Amitabh Dube and Sheetal Arora named Co-Chairmen for the forthcoming term
This marks one of the most closely watched oncology readouts at this year’s medical congress
If cleared, MAVIRET would become one of the few therapies in the European Union approved to treat both acute and chronic hepatitis C infections
The recommendation is powered by blockbuster results from the pivotal Phase III SERENA-6 trial
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
